TINA MILLER: Open Payments
NPI 1407195159 · MILLINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 13 payments from 12 companies in 2025. Trend: 2023 $2,028 · 2024 $2,667 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $28 |
| UCB, Inc. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Biogen, Inc. | 1 | $25 |
| Celgene Corporation | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: QULIPTA, Nayzilam, INGREZZA, VUMERITY, ZEPOSIA, CREXONT, REXULTI, Wegovy.
Industry payments across TN — which companies pay providers there.
